Kawasaki disease: Insights into pathogenesis and approaches to treatment

Keyphrases

• Kawasaki Disease 100%
• Genetic Factors 20%
• Incidence Rate 20%
• Patient Management 20%
• Increased Incidence 20%
• High Risk 20%
• Adjunctive Therapy 20%
• High Incidence 20%
• Causative Agents 20%
• Most Common Cause 20%
• Recent Advances 20%
• Treatment Decisions 20%
• Aspirin 20%
• Clinical High Risk 20%
• Myocardial Ischemia 20%
• Coronary Arteritis 20%
• Base Treatment 20%
• Pathophysiologic Mechanisms 20%
• Developed Countries 20%
• Infarction 20%
• Acquired Heart Disease 20%
• Ethnically Diverse Populations 20%
• Epidemiological Data 20%
• Process Mechanism 20%
• Corticosteroids 20%
• Pathologic Processes 20%
• Infectious Etiology 20%
• Asian Ethnicity 20%
• Intravenous Immunoglobulin (IVIg) 20%
• Japanese Population 20%
• Coronary Artery Abnormalities 20%
• First-degree Family Members 20%
• Timely Administration 20%
• Coronary Complications 20%

Medicine and Dentistry

• Kawasaki Disease 100%
• Heredity 20%
• Adjuvant Therapy 20%
• Immunoglobulin 20%
• Physical Disease by Body Function 20%
• Infarction 20%
• Coronary Artery 20%
• Heart Muscle Ischemia 20%
• Acetylsalicylic Acid 20%
• Heart Disease 20%
• Arteritis 20%
• Base 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Mucocutaneous Lymph Node Syndrome 100%
• Heart Disease 20%
• Infarction 20%
• Heart Muscle Ischemia 20%
• Immunoglobulin 20%
• Acetylsalicylic Acid 20%
• Physical Disease by Body Function 20%
• Base 20%
• Arteritis 20%